|
|
|
Volumn 52, Issue SUPPL. 2, 1997, Pages
|
|
Current best practice for nebuliser treatment: Introduction
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADRENALIN;
AMINOPHYLLINE;
ANTIBIOTIC AGENT;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
BRONCHODILATING AGENT;
BUDESONIDE;
BUPIVACAINE;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CLINDAMYCIN;
COLISTIN;
CORTICOSTEROID;
COTRIMOXAZOLE;
DAPSONE;
DORNASE ALFA;
GENTAMICIN;
HYDROCORTISONE;
IPRATROPIUM BROMIDE;
LIDOCAINE;
OPIATE AGONIST;
PENTAMIDINE;
PREDNISOLONE;
PROSTACYCLIN;
PYRIMETHAMINE;
RIBAVIRIN;
SALBUTAMOL;
SODIUM CHLORIDE;
TERBUTALINE;
THEOPHYLLINE;
TOBRAMYCIN;
UNINDEXED DRUG;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ASTHMA;
BRONCHIECTASIS;
BRONCHODILATATION;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL PRACTICE;
CLINICAL TRIAL;
CROUP;
CYSTIC FIBROSIS;
HOME CARE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INHALATIONAL DRUG ADMINISTRATION;
INTENSIVE CARE;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG INFECTION;
MEDICAL NEBULIZER;
METERED DOSE INHALER;
NEBULIZATION;
ORAL DRUG ADMINISTRATION;
PHYSIOTHERAPY;
PNEUMOCYSTIS PNEUMONIA;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
REVIEW;
BRONCHODILATOR AGENTS;
DRUG DELIVERY SYSTEMS;
HUMANS;
LUNG DISEASES, OBSTRUCTIVE;
NEBULIZERS AND VAPORIZERS;
|
|
EID: 0030982725
PISSN: 00406376
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (48)
|
|
References (5)
|